Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer
Titel:
Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer
Auteur:
Seidman, A.D. Brufsky, A. Ansari, R.H. Hart, L.L. Stein, R.S. Schwartzberg, L.S. Stewart, J.F. Russell, C.A. Chen, S.-C. Fein, L.E. De La Cruz Vargas, J.A. Kim, S.-B. Cavalheiro, J. Zhao, L. Gill, J.F. Obasaju, C.K. Orlando, M. Tai, D.F.